d-alpha tocopherol has been researched along with plx4032 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, D; Eberle, J; Kiecker, F; Nguyen, HA; Werth, F | 1 |
Anastasia, A; Bani, MR; Beretta, G; Fontana, F; Limonta, P; Marelli, MM; Marzagalli, M; Messi, E; Moretti, RM | 1 |
2 other study(ies) available for d-alpha tocopherol and plx4032
Article | Year |
---|---|
Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Indoles; MAP Kinase Signaling System; Melanoma; Membrane Potential, Mitochondrial; Oximes; Potassium Channels; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Reactive Oxygen Species; Signal Transduction; Sulfonamides; Vemurafenib; Vitamin E | 2017 |
Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Biomarkers, Tumor; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Indoles; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Melanoma; Neoplasm Proteins; Neoplastic Stem Cells; SOXB1 Transcription Factors; Spheroids, Cellular; Sulfonamides; Vemurafenib; Vitamin E | 2018 |